Pharmaceutical Giants Win 2008 China Charity Awards
This article was originally published in PharmAsia News
Executive Summary
China's Ministry of Civil Affairs recently announced its 2008 China Charity Award, which recognizes the outstanding achievements of individuals, enterprises and charity programs in 2008. The award represents the most prestigious in the country honoring corporate social responsibility. In the foreign company segment, pharmaceutical and medical device manufacturers Sanofi-Aventis, AstraZeneca, Novartis, Hualan Biological Engineering, Dupromise Medicine, Siemens and Canon China are among the winners. Following the Sichuan earthquake in May this year, Sanofi and Novartis each donated RMB 15 million ($2 million) in cash and medicine, while AstraZeneca allocated some RMB 14.6 million worth of donations, medicine and materials to support post-disaster reconstruction (PharmAsia News, May 19, 2008). (Click here for more - Chinese Language)
You may also be interested in...
Pharmaceutical MNC Donations Pour In For Quake Victims
Donations have been pouring in for the Sichuan earthquake victims in China, with pharmaceutical MNCs doing their part. PharmAsia News provides a round up below of medical product company contributions as reported in the Chinese media
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.